TRVI Earnings

Quarterly EPS
$-0.13
Q3 2024
$-0.11
Q4 2024
$-0.09
Q1 2025
$-0.09
Q2 2025
$-0.08
Q3 2025
$-0.06
Q4 2025
$-0.09
Q1 2026
$-0.11
Q2 2026
Latest RevenueN/A
Latest Net Income-17797000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.110-17797000-22.2%
Q1 2026-$0.090-13192000+0.0%
Q4 2025-$0.060-8316000+45.5%
Q3 2025-$0.080-11802000+38.5%
Q2 2025-$0.090-12301000+25.0%
Q1 2025-$0.090-10340000+18.2%
Q4 2024-$0.110-11415000-37.5%
Q3 2024-$0.130-13242000-62.5%
Q2 2024-$0.120-12352000
Q1 2024-$0.110-10902000
Q4 2023-$0.080-7821000
Q3 2023-$0.080-7698000
Trevi Therapeutics (TRVI) — Earnings